NAGE

Niagen Bioscience, Inc. Common Stock
NAGE

Overview Fund Activity

96 hedge funds and large institutions have $211M invested in Niagen Bioscience, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 24 increasing their positions, 33 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
+13
Holders Change %
+15.66%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
29
Increased
24
Reduced
33
Closed
16
Calls
$8.87M
Puts
$9.92M
Net Calls
-$1.05M
Net Calls Change
-$1.1M

Top Buyers

1
YRHAM
Yong Rong (HK) Asset Management
Hong Kong
+$38.6M
2
Bank of America
Bank of America
North Carolina
+$13.2M
3
Millennium Management
Millennium Management
New York
+$7.59M
4
Invesco
Invesco
Georgia
+$7.58M
5
Group One Trading
Group One Trading
Illinois
+$5.78M

Top Sellers

1
TCM
Tieton Capital Management
Washington
-$7.87M
2
UIC
Uniplan Investment Counsel
Wisconsin
-$3.85M
3
IC
Iconiq Capital
California
-$3.84M
4
SA
Sycale Advisors
New York
-$3.43M
5
Morgan Stanley
Morgan Stanley
New York
-$3.35M
Name Holding Trade Value Shares
Change 		Shares
Change %
HSBC Holdings
101
HSBC Holdings
United Kingdom
– -$136K -28,057 Closed
AG
102
Algert Global
California
– -$131K -27,340 Closed
Two Sigma Advisers
103
Two Sigma Advisers
New York
– -$105K -21,800 Closed
CS
104
Credit Suisse
Switzerland
– -$63K -13,147 Closed
HW
105
Hancock Whitney
Mississippi
– -$60K -12,528 Closed
AIP
106
Ahrens Investment Partners
Louisiana
– -$53K -11,000 Closed
PP
107
PDT Partners
New York
– -$52K -10,738 Closed
Principal Financial Group
108
Principal Financial Group
Iowa
– -$51K -10,521 Closed
PCA
109
Peddock Capital Advisors
Massachusetts
– -$16K -3,380 Closed
LGA
110
Lebenthal Global Advisors
New York
– -$4K -934 Closed
RE
111
RBC Europe
United Kingdom
– -$797 -166 Closed
1 2 3 4
5